Results 191 to 200 of about 22,304 (253)

Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice?

Gynecological Endocrinology, 2021
Objective Combined oral contraceptives (COC) and progestogens are widely used for the treatment of endometriosis. The objective of the study is to compare the efficacy of dienogest 2 mg vs continuous oral levonorgestrel/EE (levonorgestrel 0.1 mg/ethinyl ...
I. Piacenti   +8 more
semanticscholar   +1 more source

Effects of the Gestagen Levonorgestrel in a Life Cycle Test with Zebrafish (Danio rerio)

Environmental Toxicology and Chemistry, 2021
The amount of pharmaceuticals transferred to the aquatic environment via municipal and hospital waste water is steadily increasing. The progress in medical research has resulted in the manufacture of active substances of increased stability, specificity,
M. Teigeler   +4 more
semanticscholar   +1 more source

Major differences in the characteristics of users of the copper intrauterine device or levonorgestrel intrauterine system at a clinic in Campinas, Brazil

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2021
To compare the sociodemographic characteristics of users of the copper intrauterine device (Cu‐IUD) and the levonorgestrel intrauterine system (LNG‐IUS) at a family planning clinic in Campinas, SP, Brazil.
Montas Laporte   +3 more
semanticscholar   +1 more source

An Atomically Precise Gold-Levonorgestrel Nanocluster as a Radiosensitizer for Enhanced Cancer Therapy.

ACS Nano, 2019
Gold nanoclusters have become promising radiosensitizers due to their ultrasmall size and robust ability to adsorb, scatter and re-emit radiation. However, most of the previously reported gold nanocluster radiosensitizers do not have a precise atomic ...
Tongtong Jia   +10 more
semanticscholar   +1 more source

Levonorgestrel intrauterine system for the treatment of intermenstrual spotting in patients with previous cesarean delivery scar defect

The journal of obstetrics and gynaecology research, 2021
To evaluate the efficacy of levonorgestrel 52 mg intrauterine system for intermenstrual bleeding in patients with previous cesarean delivery scar defects (PCDSs).
Y. Ou   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy